Technology | 2016.01.21
Wistar Startup Immunaccel Aims to Accelerate the Translation of Immuno- Oncology Therapies - Newswise (press release)
| Wistar Startup Immunaccel Aims to Accelerate the Translation of Immuno- Oncology Therapies Newswise (press release) Newswise — PHILADELPHIA—(Jan. 20, 2016)—Cancer immunotherapies have proven to be very successful in stimulating the body's own immune system to recognize and combat cancer, placing the groundbreaking drugs at the forefront of research and ... |
For more information, please visit
http://news.google.com/news/url?sa=t&fd=[...]munaccel-aims-to-accelerate-th
